IRIS
MARCENARO, EMANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.817
AS - Asia 14
SA - Sud America 4
NA - Nord America 2
Totale 19.837
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 19.817
CN - Cina 13
BR - Brasile 4
US - Stati Uniti d'America 2
VN - Vietnam 1
Totale 19.837
Salva come PNG Salva come JPEG
Città #
Genova 11.514
Genoa 5.159
Rapallo 1.653
Vado Ligure 1.437
Bordighera 51
Beijing 6
Milan 2
Ashburn 1
Brasília 1
Dallas 1
Erechim 1
Hanoi 1
Ribeirão Preto 1
Salvador 1
Totale 19.829
Salva come PNG Salva come JPEG
Nome #
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 190
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 186
2B4 functions as a co-receptor in human NK cell activation 184
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 184
Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals. 180
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 174
Features of Memory-Like and PD-1+ Human NK Cell Subsets 173
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 173
NK/DC crosstalk in anti-viral response. 172
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. 168
Bridging innate NK cell Functions with Adaptive Immunity. 167
IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors 167
TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses 162
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor 162
NK cells and their receptors during viral infections. 161
Markers and function of human NK cells in normal and pathological conditions 160
Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma 157
Role of the 2B4 receptor in CD8+ T-cell-dependent immune control of Epstein-Barr virus infection in mice with reconstituted human immune system components 156
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway 156
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 156
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 156
Multi-directional cross-regulation of NK cell function during innate immune responses. 153
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 150
Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines 148
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 148
Harnessing NK Cells for Cancer Treatment 147
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression 146
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. 145
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation 145
Human Natural Killer Cells exposed to IL-2, IL12, IL-18 or IL-4 differently modulate priming of naïve T cells by monocyte-derived Dendritic Cells. 144
Human NK cell response to pathogens 143
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 143
NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells 140
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML 139
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 137
Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1β, IFN-β, and IL-15 Pathways 137
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 137
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. 136
Natural killer lymphocytes: "null cells" no more. 136
Adoptive Cell Therapy and Immune Check Points Inhibitors As a Salvage Treatment for Patient Affected By Relapsed/Refractory Hodgkin's Lymphoma 136
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 135
Pathogen-induced private conversations between natural killer and dendritic cells 134
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 134
Innate immunity defects in Hermansky-Pudlak type 2 syndrome 133
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 131
Natural killer cell-triggering receptors in patients with acute leukaemia. 130
TLR/NCR/KIR: Which One to Use and When? 130
It's only innate immunity but I like it 130
Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. 129
Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapy 129
Identification of NKG2A and NKp80 as specific Natural Killer cell markers in rhesus and pigtailed monkeys 128
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 128
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues 127
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 127
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 127
Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. 126
Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism. 126
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment 126
CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. 125
Early liaisons between cells of the innate immune system in inflamed peripheral tissues 125
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors 124
Unraveling the regulatory role of NK cells on T-cell effector functions: Implications for CNS autoimmunity 124
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands 124
Primitive Neuroectodermal Tumor in an Ovarian Cystic Teratoma: Natural Killer and Neuroblastoma Cell Analysis 123
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 123
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis 120
The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer cell subsets associated with high levels of HIV-1 viremia. 119
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia 118
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 118
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. 118
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 118
NK cells: innate immunity against hematological malignancies? 118
Downregulation of HLA Class I Renders Inflammatory Neutrophils More Susceptible to NK Cell-Induced Apoptosis 118
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes 118
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 116
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 115
IL-12 or IL-4 prime human Natural Killer cells to mediate functionally divergent interactions with Dendritic cells or tumors 114
Human NK cells directly recognize Mycobacterium Bovis and acquire the ability to interact with monocyte-derived DC 114
Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. 114
NK-DC interaction: On the usefulness of auto-aggression 113
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. 112
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 111
Natural killer cells in HIV-Infectious: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. 110
Editorial: NK Cell Subsets in Health and Disease: New Developments 110
Human NK cells directly recognize Mycobacterium bovis and acquire the ability to interact with monocyte-derived DC 110
Adaptor protein 3 complex deficiency causes innate immunity defects 110
IL-12 or IL-4 prime human natural killer cells to mediate functionally divergent interactions with dendritic cells or tumors 109
Human Natural Killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection 109
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 109
The NK/DC complot 109
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection 108
Cognate HLA absence in trans diminishes human NK cell education 107
Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. 106
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines. Regulation by KIR/HLA-class I interaction. 106
Monoclonal Antibodies against NKG2A 106
IL-12 or IL-4 prime human Natural Killer Cells to mediate functionally diverent interactions with dendritic cells or tumors 105
New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR- 146a-5p in the regulation of KIR expression 105
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 104
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts. 103
Monoclonal Antibodies against NKG2A 103
Totale 13.355
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.919
article - articoli 52.664
book - libri 565
conference - conferenze 7.595
curatela - curatele 0
other - altro 435
patent - brevetti 4.563
selected - selezionate 0
volume - volumi 2.097
Totale 135.838
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.115 0 0 0 96 53 233 44 113 119 217 105 135
2021/20222.122 77 160 151 183 116 118 142 495 156 186 95 243
2022/20232.047 238 154 23 194 297 348 4 178 381 21 178 31
2023/20241.164 63 177 34 136 93 122 80 125 69 48 80 137
2024/20253.516 76 260 133 229 511 337 363 501 117 191 375 423
2025/20261.652 706 177 420 349 0 0 0 0 0 0 0 0
Totale 20.325